期刊文献+

喹硫平治疗男性精神分裂症临床效应与剂量、血药浓度的关系 被引量:3

Relationship between serum concentration and clinical efficacy of quetiapine in treatment of male patients with schizophrenia
原文传递
导出
摘要 目的:探讨喹硫平治疗男性精神分裂症患者的血药浓度与临床疗效的关系。方法纳入63例住院男性精神分裂症患者;口服喹硫平片治疗8周,根据疗效和耐受性调整剂量。治疗4、8周末分析患者的血药浓度、疗效及副作用。结果4周喹硫平血药浓度与年龄(r=0.297)、病程(P=0.315)呈正相关,与文化程度(r=-0.297)呈负相关;8周血药浓度与年龄呈正相关(r=0.318)。4周喹硫平血药浓度与4周剂量存在正相关(r=0.429);8周喹硫平血药浓度与8周剂量存在正相关(r=0.292)。喹硫平血药浓度与阳性和阴性症状量表PANSS减分率无明显相关(P>0.05)。喹硫平治疗4、8周时的副作用与4周血药浓度存在正相关。结论喹硫平可有效治疗男性精神分裂症患者;年龄、剂量和副作用与血药浓度存在相关性。喹硫平血药浓度与临床疗效无明显关联。 Objective To examine the relationship between quetiapine serum concentration,dose,therapeu-tic efficacy and side effects in male patients with schizophrenia.Methods Sixty-three male patients with schizo-phrenia were collected.They were treated openly for 8 weeks with quetiapine,the dose was adjusted according to clini-cal improvement and tolerance.The plasma quetiapine concentrations,therapeutic efficacy and adverse drug reactions were observed after the 4 -week treatment period,and at the end of the 8 weeks of the treatment.Results After 4 weeks,the serum concentration had significant correlation with age,the disease duration and education level.After 8 weeks,there was significant correlation between serum concentration and age.We found a correlation between dose and serum concentration of quetiapine,and no relationship between serum concentration and PANSS scores.Side effects were correlated with 4 weeks′serum concentrations.Conclusion Quetiapine is effective for male patients with schizophrenia.Age,quetiapine dose and side effects have significant correlations with the serum concentration.It appears that plasma quetiapine concentration has no effects on therapeutic efficacy.
出处 《中国基层医药》 CAS 2015年第7期1002-1005,共4页 Chinese Journal of Primary Medicine and Pharmacy
基金 浙江省医学会临床科研资金项目(2011ZYC-A60)
关键词 精神分裂症 血药浓度 喹硫平 Schizophrenia Plasma concentration Quetiapine
  • 相关文献

参考文献15

  • 1Gobbi G,Comai S, Debonnel G. Effects of quetiapine and olanza- pine in patients with psychosis and violent behavior:a pilot ran- domized, open-label, comparative study [ J ]. Neuropsychiatr Dis Treat,2014,10 (5) :757-765.
  • 2唐茂芹,胡蕾,王松波,刘兰芬,刘同洲,李宪伟,刘增训,李万顺,付崇铭.奎硫平治疗精神分裂症的血药浓度与临床效应关系的研究[J].中华精神科杂志,2004,37(2):85-87. 被引量:27
  • 3Sparshatt A, Taylor D, Patel MX, et al. Relationship between daily dose, plasma concentrations, dopamine receptor occupancy, and clinical response to quetiapine : a review [ J ]. J Clin Psychiatry, 2011,72(8) :1108-1123.
  • 4Castberg I, Skogvoll E, Spigset O. Quetiapine and drug interac- tions:evidence from a routine therapeutic drug monitoring service [ J ]. J Clin Psychiatry ,2007,68 (10) : 1540-1545.
  • 5Aichhorn W, Marksteiner J, Walch T, et al. Influence of age, gen- der, body weight and valproate comedication on quetiapine plasma concentrations[ J] Int Clin Psychopharmacol, 2006,21 ( 2 ) : 81 - 85.
  • 6Potkin SG, Thyrum PT, Alva G. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine[ J ]. J Clin Psychopharmacol, 2002,22 ( 2 ) : 121 - 130.
  • 7傅崇铭,张桂华,唐茂芹,郭瑞臣.精神分裂症患者富马酸喹硫平血药浓度测定及其与临床效应的相关性[J].中国药学杂志,2004,39(12):928-930. 被引量:15
  • 8刘红梅,林治光,任娟娟,崔慧茹,蒋平,朱怡康,孙秀佳,李春波.喹硫平药物浓度监测及临床参考值范围的初步建立[J].世界临床药物,2012,33(10):612-615. 被引量:7
  • 9Baumann P, Hiemke C, Ulrich S, et al. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psy- chiatry [ J ]. Pharmacopsychiatry ,2004,37 ( 6 ) :243-265.
  • 10Gerlach M, Hiinnerkopf R, Rothenhfer S. Therapeutic drug moni- toring of quetiapine in adolescents with psychotic disorders [ J ]. Pharmaeopsychiatry,2007,40 ( 2 ) : 72 -76.

二级参考文献45

共引文献80

同被引文献25

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部